| abstract |
The present disclosure relates to 5-chloro-N2- (2-isopropoxy-5-methyl-4- (piperidin-4-yl) phenyl) -N4- [2- (propane-2-sulfonyl) -phenyl] -pyrimidine- It relates to a process for synthesizing 2,4-diamine (seritinib) and / or its intermediates, their use as pharmaceuticals and pharmaceutical compositions, and the use of intermediates for preparing ceritinib. |